Loss of JCAD/KIAA1462 Protects the Lung from Acute and Chronic Consequences of Chronic Obstructive Pulmonary Disease
International Journal of Molecular Sciences · 31.08.2024 · 25 (17) · 9492
DOI: 10.3390/ijms25179492 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 31.08.2024. Verfasst von Ratoe Suraya und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. Hauptthemen laut MEDLINE: Endothelial Cells, Lung, Mice, Knockout, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, JSPS KAKENHI.
Themen: COPD
Abstract (Originalsprache)
Even with recent advances in pathobiology and treatment options, chronic obstructive pulmonary disease (COPD) remains a major contributor to morbidity and mortality. To develop new ways of combating this disease, breakthroughs in our understanding of its mechanisms are sorely needed. Investigating the involvement of underanalyzed lung cell types, such as endothelial cells (ECs), is one way to further our understanding of COPD. JCAD is a junctional protein in endothelial cells (ECs) arising from the KIAA1462 gene, and a mutation in this gene has been implicated in the risk of developing COPD. In our study, we induced inflammation and emphysema in mice via the global knockout of KIAA1462/JCAD (JCAD-KO) and confirmed it in HPMECs and A549 to examine how the loss of JCAD could affect COPD development. We found that KIAA1462/JCAD loss reduced acute lung inflammation after elastase treatment. Even after 3 weeks of elastase, JCAD-KO mice demonstrated a preserved lung parenchymal structure and vasculature. In vitro, after KIAA1462 expression is silenced, both endothelial and epithelial cells showed alterations in pro-inflammatory gene expression after TNF-α treatment. We concluded that JCAD loss could ameliorate COPD through its anti-inflammatory and anti-angiogenic effects, and that KIAA1462/JCAD could be a novel target for COPD therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Respiratory Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
- Laboratory of Clinical Pharmaceutical Science, Kobe Pharmaceutical University, Kobe 658-8558, Japan.
- Department of Oral and Maxillofacial Surgery, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
ORCID-Profile: Ratoe Suraya, Tatsuya Nagano, Motoko Tachihara, Kazuyuki Kobayashi
Förderung
- Japan Society for the Promotion of Science
- JSPS KAKENHI
Zitieren
APA
Suraya, R., Nagano, T., Yumura, M., Hara, T., Akashi, M., Yamamoto, M., Tachihara, M., Nishimura, Y., & Kobayashi, K. (2024). Loss of JCAD/KIAA1462 Protects the Lung from Acute and Chronic Consequences of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences, 25(17), 9492. https://doi.org/10.3390/ijms25179492
Vancouver
Suraya R, Nagano T, Yumura M, Hara T, Akashi M, Yamamoto M, et al. Loss of JCAD/KIAA1462 Protects the Lung from Acute and Chronic Consequences of Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences. 2024;25(17):9492. doi:10.3390/ijms25179492
BibTeX
@article{Suraya2024,
author = {Suraya, Ratoe and Nagano, Tatsuya and Yumura, Masako and Hara, Tetsuya and Akashi, Masaya and Yamamoto, Masatsugu and Tachihara, Motoko and Nishimura, Yoshihiro and Kobayashi, Kazuyuki},
title = {Loss of JCAD/KIAA1462 Protects the Lung from Acute and Chronic Consequences of Chronic Obstructive Pulmonary Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9492},
doi = {10.3390/ijms25179492}
}
EUVIMED